Analyst favorites — what the screen found 2026-10-02

Among the 40 companies passing today’s screen for a strong-buy-leaning consensus from real coverage, Manufacturing stands out with 26 of these names concentrated in this sector. This concentration underscores a notable theme but does not imply investment merit on its own.

MakeMyTrip Limited (MMYT) is one standout with a market cap of $4.41B and an analyst rating of 1.0, indicating unanimous strong buy recommendations¹². Immunic, Inc. Common Stock (IMUX), another Manufacturing company, has a smaller market cap at $127.51M but also receives a 1.0 analyst rating.

Palvella Therapeutics, Inc. Common Stock (PVLA) is worth noting for its strong buy consensus and $2.02B market cap in the Manufacturing sector³. First Watch Restaurant Group, Inc. Common Stock (FWRG), while not in Manufacturing, also receives a 1.0 analyst rating and boasts a market cap of $627.00M⁴.

Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) rounds out the list with a solid strong buy consensus and a market cap of $529.91M, also in Manufacturing⁵. Corbus Pharmaceuticals Holdings, Inc. (CRBP), another company in this sector, has an analyst rating of 1.0 and a market cap of $139.55M⁶.

It's important to note that passing this screen simply indicates these companies have received strong buy recommendations from analysts — it does not establish their value or future performance potential. This screen is merely a starting point for further analysis, not a definitive investment recommendation.